Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/13/2003US6562329 Administering lipase inhibitors
05/13/2003US6562326 Topical composition for burn healing
05/13/2003US6562321 Topical; carrier and one of 3,3'-thiodipropionic acid, thiazolidine-2-carboxylic acid, and kaempferol-7-glucoside, or their derivatives
05/13/2003US6562319 4-(phenylamino)quinazolines
05/13/2003CA2315877C Facilitated oxygen delivery in conjunction with hemodilution
05/13/2003CA2300679C Method of reducing intestinal gas, cramping and anorectal irritation
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2259655C 1,4-di-sustituted piperidines as muscarinic antagonists
05/13/2003CA2235607C Process for aqueous granulation of clarithromycin
05/13/2003CA2202992C Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/13/2003CA2173863C 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
05/13/2003CA2151937C Antiplaque, antigingivitis, anticaries oral composition
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2096575C Novel simethicone containing pharmaceutical compositions
05/13/2003CA2080402C Avermectin compounds with a 6,5-spiroketal ring system and a 23-acyl substituent
05/13/2003CA2048980C 1-(pyridinylalkyl)-1h-indoles, indolines and related analogs
05/13/2003CA2045885C Inhibition of mammalian muscle wasting and protein degradation by tetracyclines
05/10/2003WO2002036120A1 Use of stimulators of soluble guanylate cyclase for treating osteoporosis
05/10/2003CA2427551A1 Use of stimulators of soluble guanylate cyclase for treating osteoporosis
05/09/2003CA2464707A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/08/2003WO2003038129A2 Methods for assessing and treating leukemia
05/08/2003WO2003038128A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038118A1 Method of evaluating phosphatase inhibitors
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038109A2 Method for the inhibition of methanogenesis
05/08/2003WO2003038089A1 Probe solutin compositions, reactive chip using the same and process for the production thereof
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038080A1 Crystal structure of phosphodiesterase 5 and use thereof
05/08/2003WO2003038060A2 Small molecule inhibitors targeted at bcl-2
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038036A2 Rescue of gonadotropin releasing hormone receptor mutants
05/08/2003WO2003038032A2 Means for inhibition of the synthesis of viral proteins
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037909A1 Acyclic linker-containing oligonucleotides and uses thereof
05/08/2003WO2003037908A1 Antiviral combination therapy and compositions
05/08/2003WO2003037905A1 Silicon compounds
05/08/2003WO2003037904A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2003037901A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003WO2003037900A2 Pyrazolopyrimidines
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037897A2 Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2003037895A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037894A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037893A1 Acyl dihydro pyrrole derivatives as hcv inhibitors
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037890A2 Piperidines
05/08/2003WO2003037889A1 Compounds and method for the treatment of overactive bladder
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037886A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037873A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037870A1 Substituted 1h-quinolin-2-one compounds
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037866A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037861A1 Use of 2-acylindoles in the treatment of tumors
05/08/2003WO2003037860A2 Purine analogs having hsp90-inhibiting activity
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037845A1 Compositions for treating acne comprising phytandiol amine
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037385A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037382A1 Low concentration of peroxide for treating or preventing vaginal infections
05/08/2003WO2003037381A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
05/08/2003WO2003037380A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/08/2003WO2003037379A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037376A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
05/08/2003WO2003037375A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003WO2003037373A1 Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037356A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide
05/08/2003WO2003037355A1 Polyacrylate compositions for use in protecting mucosa
05/08/2003WO2003037354A1 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037348A1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia
1 ... 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 5488 5489 5490 5491 5492 5493 ... 7860